This is in contrast to the findings in the Asian patients where all of the LKB1 mutations were detected in adenocarcinomas (9 out of 113 (8%)) and none were detected in squamous cell cancers (0 out of 54 (0%); P=0.032). This evidence concerns the gene STK11 and squamous cell carcinoma.